Abstract:NMDA receptors (NMDARs) are ionotropic glutamate receptors that are crucial for neuronal development and higher cognitive processes. NMDAR dysfunction is involved in a variety of neurological and psychiatric diseases; however, the mechanistic link between the human pathology and NMDAR dysfunction is poorly understood. Rare missense variants within NMDAR subunits have been identified in numerous patients with mental or neurological disorders. We specifically focused on the GluN2B NMDAR subunit, which is highly expressed in the hippocampus and cortex throughout development. We analyzed several variants located in the GluN2B C terminus and found that three variants in patients with autism (S1415L) or schizophrenia (L1424F and S1452F) (S1413L, L1422F, and S1450F in rodents, respectively) displayed impaired binding to membrane-associated guanylate kinase (MAGUK) proteins. In addition, we observed a deficit in surface expression for GluN2B S1413L. Furthermore, there were fewer dendritic spines in GluN2B S1413L-expressing neurons. Importantly, synaptic NMDAR currents in neurons transfected with GluN2B S1413L in GluN2A/B-deficient mouse brain slices revealed only partial rescue of synaptic current amplitude. Functional properties of GluN2B S1413L in recombinant systems revealed no change in receptor properties, consistent with synaptic defects being the result of reduced trafficking and targeting of GluN2B S1413L to the synapse. Therefore, we find that GluN2B S1413L displays deficits in NMDAR trafficking, synaptic currents, and spine density, raising the possibility that this mutation may contribute to the phenotype in this autism patient. More broadly, our research demonstrates that the targeted study of certain residues in NMDARs based on rare variants identified in patients is a powerful approach to studying receptor function. SIGNIFICANCE STATEMENT We have used a “bedside-to-bench” approach to investigate the functional regulation of NMDA receptors (NMDARs). Using information from deep sequencing of patients with neurological or psychiatric disorders, we investigated missense variants identified in the intracellular C-terminal domain of the GluN2B NMDAR subunit. We found several variants that displayed altered properties. In particular, one variant identified in a patient with autism, human GluN2B S1415L, displayed reduced surface expression and binding to PSD-95. Furthermore expression of GluN2B S1415L (S1413L in mouse) showed a deficit in rescue of synaptic NMDAR currents and fewer dendritic spines, consistent with other reports of spine abnormalities being associated with autism. More broadly, we demonstrate that using patient data is an effective approach to probing the structure/function relationship of NMDARs.

Analyses of Human Genetic Data to Identify Clinically Relevant Domains of Neuroligins

A Review on the Current Neuroligin Mouse Models.

Diagnostic Classification and Prognostic Prediction Using Common Genetic Variants in Autism Spectrum Disorder: Genotype-Based Deep Learning

Using Structural Analysis to Clarify the Impact of Single Nucleotide Variants in Neurexin/neuroligin Revealed in Clinical Genomic Sequencing

Variations Analysis of NLGN3 and NLGN4X Gene in Chinese Autism Patients

Analyses of the Autism-Associated Neuroligin-3 R451C Mutation in Human Neurons Reveal a Gain-of-function Synaptic Mechanism

Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing

A Sex-Specific Association of Common Variants of Neuroligin Genes (NLGN3 and NLGN4X) with Autism Spectrum Disorders in a Chinese Han Cohort

Autism-linked NLGN3 is a key regulator of gonadotropin-releasing hormone deficiency

The association analysis of RELN and GRM8 genes with autistic spectrum disorder in Chinese Han population.

Quantitative Spatial Analysis of Neuroligin-3 mRNA Expression in the Enteric Nervous System Reveals a Potential Role in Neuronal-Glial Synapses and Reduced Expression in Nlgn3R451C Mice

A Neuroligin-4 Missense Mutation Associated with Autism Impairs Neuroligin-4 Folding and Endoplasmic Reticulum Export

Novel Gene-Based Analysis of ASD GWAS: Insight Into the Biological Role of Associated Genes

Excess of RALGAPB De Novo Variants in Neurodevelopmental Disorders

eQTL colocalization analysis highlights novel susceptibility genes in Autism Spectrum Disorders (ASD)

Novel mutations of NLGN3 and NLGN4X gene identified in Chinese autism patients.

A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density

Analysis of the SNP Rs3747333 and Rs3747334 in NLGN4X Gene in Autism Spectrum Disorder: a Meta-Analysis

Nuclear access of DNlg3 c-terminal fragment and its function in regulating innate immune response genes

A novel framework for functional annotation of variants of uncertain significance in ID/ASD risk gene CC2D1A

Identification and Functional Analysis of Long Non-coding RNAs in Autism Spectrum Disorders